)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
DexTech Medical (DEX) investor relations material
DexTech Medical Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary29 Aug, 2025
Executive summary
No net sales were recorded for the year or quarter; operations focused on R&D and clinical trials.
Operating loss for the year was SEK -5.3 million, slightly improved from SEK -5.5 million year-over-year.
Cash and cash equivalents at year-end were SEK 14.7 million, down from SEK 19.0 million.
The ongoing myeloma Phase 1 study showed 67% of patients achieved stable disease, with no significant side effects.
European patent granted for GMP manufacture of OsteoDex, supporting future market exclusivity.
Financial highlights
Net sales: SEK 0.0 million for both the quarter and full year, unchanged year-over-year.
Operating profit: SEK -1.6 million for Q4, SEK -5.3 million for the year, both slightly improved from prior periods.
Earnings per share: SEK -0.08 for Q4, SEK -0.26 for the year, marginally lower than last year.
Cash flow for the year: SEK -4.3 million, improved from SEK -6.2 million prior year.
Equity at year-end: SEK 24.8 million, equity/assets ratio 99%.
Outlook and guidance
Operations are financed until Q4 2026 due to reduced costs and previous rights issue.
The ongoing myeloma Phase 1 study is expected to complete in Q4 2025.
License revenues are targeted to finance operations beyond 2026.
Continued focus on out-licensing drug candidates after phase II studies.
ODX MM efficacy vs. existing drugs
CRPC Phase III partnership status?
Funding plan if no license revenue by Q4 2026?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next DexTech Medical earnings date
Q1 20263 Nov, 2025
Next DexTech Medical earnings date
Q1 20263 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
DexTech Medical AB is a Sweden-based medical technology company specializing in the development of diagnostic and therapeutic solutions for oncology. The company focuses on creating proprietary products for the treatment and management of cancer, with an emphasis on prostate cancer and related conditions. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Spotlight Stock Market.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage